BNTC insider trading

NasdaqCM Healthcare

Benitec Biopharma Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
57
Last 90 days
1
Buys / sells
67% / 0%
Market cap
$371.32M

About Benitec Biopharma Inc.

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Company website: benitec.com

BNTC insider activity at a glance

FilingIQ has scored 57 insider transactions for BNTC since Apr 28, 2021. The most recent filing in our index is dated May 26, 2026.

Across the full history, 38 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on BNTC insider trades is 52.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for BNTC?
FilingIQ tracks 57 Form 4 insider transactions for BNTC (Benitec Biopharma Inc.), covering filings from Apr 28, 2021 onwards. 1 of those were filed in the last 90 days.
Are BNTC insiders net buyers or net sellers?
Across the full Form 4 history for BNTC, 38 transactions (67%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does BNTC insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is BNTC in?
Benitec Biopharma Inc. (BNTC) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $371.32M.

Methodology & sources

Every BNTC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.